XML 99 R87.htm IDEA: XBRL DOCUMENT v3.20.2
REVISION OF PRIOR PERIOD FINANCIAL STATEMENTS - Cash Flow (Details) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2020
Jun. 30, 2020
Mar. 31, 2020
Sep. 30, 2019
Jun. 30, 2019
Mar. 31, 2019
Jun. 30, 2020
Jun. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Cash flows from operating activities:                          
Net income (loss)     $ 5,425     $ (739) $ 1,492 $ (311)   $ (617) $ (1,467) $ 2,189 $ 1,201
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:                          
Policy charges and fee income $ (914) $ (877) (996) $ (980) $ (938) (929) (1,873) (1,867) $ (2,787) (2,847) (3,778) (3,834) (3,686)
Interest credited to policyholders’ account balances 306     320 317 307   624 930 944 1,263 1,067  
Net derivative (gains) losses 1,472 6,038 (9,400) 453 237 1,633 (3,362) 1,870 (1,890) 2,323 4,012 250 (191)
Amortization and depreciation     1,330     227 1,540 420   564 675 296 386
Capitalization of deferred policy acquisition costs                 (489) (544) (754) (697) (663)
Future policy benefits     1,925     64 1,807 41 1,867 943 962 (458) 1,111
Current and deferred income taxes     1,420     175 478 14 237 30 (102) 627 (9)
Other, net     (449)       (328) (59) 46 (87) (164) (222)  
Net cash provided by (used in) operating activities     (570)     (109) (548) (425) 5 (292) (216) 61 (243)
Cash flows from financing activities:                          
Change in collateralized pledged assets     43       60   60 3      
Change in collateralized pledged liabilities     646       239   (1,973) (1,900)      
Net cash provided by (used in) financing activities     (13)       2,891   8,176 7,713      
Cash and cash equivalents, end of year $ 8,684 8,364 10,315 4,471 4,734 5,129 8,364 4,734 $ 8,684 4,471 4,405 4,469 4,814
As Previously Reported                          
Cash flows from operating activities:                          
Net income (loss)     5,447     (709) 1,505 (279)   (595) (1,436) 2,154 1,257
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:                          
Policy charges and fee income   (879) (991) (929) (941) (931) (1,870) (1,872)   (2,801) (3,738) (3,824) (3,693)
Interest credited to policyholders’ account balances       304 314 304   618   922 1,241 1,090  
Net derivative (gains) losses   6,033 (9,401) 451 236 1,630 (3,368) 1,866   2,317 4,000 231 (214)
Amortization and depreciation     1,275     239 1,506 433   535 657 257 399
Capitalization of deferred policy acquisition costs                     (754) (702) (687)
Future policy benefits     1,936     22 1,828 1   925 947 (399) 1,097
Current and deferred income taxes     1,425     183 482 23   36 (108) 633 (10)
Other, net     (448)       (329) (58)   (86) (162) (222)  
Net cash provided by (used in) operating activities     (582)     (109) (548) (425)   (292) (216) 61 (243)
Cash flows from financing activities:                          
Change in collateralized pledged assets     44       60            
Change in collateralized pledged liabilities     657       239            
Net cash provided by (used in) financing activities     (13)       2,891            
Cash and cash equivalents, end of year   8,364 10,315 4,471 4,734 5,129 8,364 4,734   4,471 4,405 4,469 4,814
Impact of Revisions                          
Cash flows from operating activities:                          
Net income (loss)     (22)     (30) (13) (32)   (22) (31) 35 (56)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:                          
Policy charges and fee income   2 (5) (51) 3 2 (3) 5   (46) (40) (10) 7
Interest credited to policyholders’ account balances       16 3 3   6   22 22 (23)  
Net derivative (gains) losses   5 1 2 1 3 6 4   6 12 19 23
Amortization and depreciation     55     (12) 34 (13)   29 18 39 (13)
Capitalization of deferred policy acquisition costs                     0 5 24
Future policy benefits     (11)     42 (21) 40   18 15 (59) 14
Current and deferred income taxes     (5)     (8) (4) (9)   (6) 6 (6) 1
Other, net     (1)       1 (1)   (1) (2) 0  
Net cash provided by (used in) operating activities     12     0 0 0   0 0 0 0
Cash flows from financing activities:                          
Change in collateralized pledged assets     (1)       0            
Change in collateralized pledged liabilities     (11)       0            
Net cash provided by (used in) financing activities     (12)       0            
Cash and cash equivalents, end of year   $ 0 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0   $ 0 $ 0 $ 0 $ 0